Register entry
- Registered sites
- 0
- Active NDC listings
- 4
- Live patents
- 24
- Exclusivities
- 1
- Countries
- 0
Catalogue
Drug listings by form and route
44 active NDC listings: 4 human prescription drug. By marketing category: NDA 4.
| Dosage form | NDCs |
|---|---|
| tablet, film coated | 3 |
| tablet | 1 |
| Route | NDCs |
|---|---|
| oral | 4 |
| Labeller name on the listing | NDCs |
|---|---|
| ardelyx, inc. | 4 |
Exclusivity
Patents and exclusivities
24| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 12016856 | IBSRELA, XPHOZAHtenapanor hydrochloride | substance, product | Dec 2029 |
| 8969377 | IBSRELA, XPHOZAHtenapanor hydrochloride | substance, product | Dec 2029 |
| 9408840 | IBSRELAtenapanor hydrochloride | use | Dec 2029 |
| 9006281 | IBSRELAtenapanor hydrochloride | use | May 2030 |
| 8541448 | IBSRELA, XPHOZAHtenapanor hydrochloride | substance, product | Aug 2033 |
| 10272079 | XPHOZAHtenapanor hydrochloride | use | Apr 2034 |
| 10940146 | XPHOZAHtenapanor hydrochloride | use | Apr 2034 |
| 12539299 | IBSRELA, XPHOZAHtenapanor hydrochloride | product | Nov 2042 |
| Product | Exclusivity | Until |
|---|---|---|
| XPHOZAHTENAPANOR HYDROCHLORIDE | NP New product | Oct 2026 |
Catalogue
Marketed products
4| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| IBSRELA | tenapanor hydrochloride | tablet, oral | 73154-050NDA |
| XPHOZAH 10 mg | Tenapanor | tablet, film coated, oral | 73154-110NDA |
| XPHOZAH 20 mg | Tenapanor | tablet, film coated, oral | 73154-120NDA |
| XPHOZAH 30 mg | Tenapanor | tablet, film coated, oral | 73154-130NDA |
Compare
Other companies listing tenapanor
- Valdepharm1 site · 17 NDC
Enquiry
Common questions
- Is Ardelyx, Inc. FDA approved?
- Ardelyx, Inc. holds no registered establishment of its own; 4 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Ardelyx, Inc. make?
- 4 products are listed under Ardelyx, Inc. in the openFDA NDC Directory, most often as tablet, film coated; tablet. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.